News - South America, Pharmaceutical

Filter

Popular Filters

1 to 25 of 99 results

Jazz Pharma gains Americas rights to defibrotide from Sigma-Tau

Jazz Pharma gains Americas rights to defibrotide from Sigma-Tau

02-07-2014

Ireland-headquartered drugmaker Jazz Pharmaceuticals has signed a definitive agreement Pharmaceuticals…

defibrotideGentiumJazz PharmaceuticalsLicensingNephrology and HepatologyNorth AmericaPharmaceuticalSigma-TauSouth America

Biopas and moksha8 in strategic alliance to commercialize drugs across Latin America

Biopas and moksha8 in strategic alliance to commercialize drugs across Latin America

16-06-2014

Panamanian drugmaker Biopas and Brazil-based moksha8 have entered into a strategic alliance combining…

BiopasMarkets & MarketingMoksha8PharmaceuticalSouth AmericaViibryd

Richter and HRA Pharma in deal on Esmya for Latin America

30-05-2014

Hungary’s largest drugmaker Gedeon Richter and France-based Laboratoire HRA Pharma have concluded a…

EsmyaGedeon RichterHRA PharmaLicensingPharmaceuticalSouth AmericaWomen's Health

Dainippon Sumitomo and Daiichi Sankyo cooperate on lurasidone in South America

Dainippon Sumitomo and Daiichi Sankyo cooperate on lurasidone in South America

28-05-2014

Japanese drug majors Dainippon Sumitomo Pharma and Daiichi Sankyo have entered into a license agreement…

ArgentinaBrazilDaiichi SankyoDainippon Sumitomo PharmaLicensinglurasidoneNeurologicalPharmaceuticalSouth AmericaVenezuela

Alliance Boots to acquire two major retail pharmacy networks in Latin America

14-05-2014

Alliance Boots, a multinational pharmacy-led health and beauty group, has recently signed an agreement…

Alliance BootsMergers & AcquisitionsPharmaceuticalSouth America

Brazil predicts 3.9 billion real in law suits against the Union for the right to access to medicines

28-04-2014

Health authorities from all government levels have been charged with law suits filed by consumers of…

BrazilHealthcareLegalPharmaceuticalSouth America

Brazil’s CMED approves price adjustment of medicines to 3.35%

04-04-2014

Brazil's National Health Surveillance Agency ANVISA’s office of pharmaceutical drug market regulation…

BrazilPharmaceuticalPricingSouth America

High incidence and inadequate treatments boost prospects of HIV, Chagas, Dengue and influenza H1N1 drugs in Latin America

High incidence and inadequate treatments boost prospects of HIV, Chagas, Dengue and influenza H1N1 drugs in Latin America

17-03-2014

The high incidence of human immunodeficiency virus (HIV), Chagas, dengue and influenza H1N1, as well…

Anti-viralsAntibiotics and Infectious diseasesGenericsMarkets & MarketingPharmaceuticalSouth America

Eli Lilly to expand manufacturing plants in Brazil’s growing pharma market

Eli Lilly to expand manufacturing plants in Brazil’s growing pharma market

03-03-2014

US pharma major Eli Lilly’s subsidiary in Brazil will invest 15 million real ($6.4 million) over the…

BrazilEli LillyPharmaceuticalPricingProductionSouth America

Increasing investment in Latin American pharma market

Increasing investment in Latin American pharma market

12-02-2014

Around $12.7 billion has been invested in Latin America’s pharmaceutical market through mergers and…

ArgentinaBrazilChileEcuadorFinancialMergers & AcquisitionsPharmaceuticalSouth America

Sorrento acquires further rights to Cynviloq to Include Australia, Canada and Mexico

11-02-2014

US cancer drug developer Sorrento Therapeutics has obtained exclusive rights to Cynviloq (marketed as…

AustraliaCanadaCynviloqMexicoOncologyPharmaceuticalSamyang BiopharmaceuticalsSorrento TherapeuticsSouth America

Mexico backs marketing of Aegerion’s Juxtapid for HoFH

Mexico backs marketing of Aegerion’s Juxtapid for HoFH

20-01-2014

US emerging biotech firm Aegerion Pharmaceuticals says that the Mexican Federal Commission for the Protection…

Aegerion PharmaceuticalsJuxtapidMexicoPharmaceuticalRare diseasesRegulationSouth America

Brazil initiates public consultation on interchangeability of biosimilar drugs

Brazil initiates public consultation on interchangeability of biosimilar drugs

17-01-2014

Biosimilar drugs, also known as follow-on biologics, may soon be substituted in place of the reference…

BiosimilarsBrazilPharmaceuticalRegulationSouth America

Brazil to produce atazanavir to supply SUS demand; strong pharma growth forecast for 2014

15-01-2014

Following the Official Gazette market application filling for the drug atazanavir sulfate, an HIV protease…

Anti-viralsatazanavirBrazilBristol-Myers SquibbFiocruzGenericsMarkets & MarketingPharmaceuticalProductionSouth America

Biotoscana to buy United Medical to create regional specialty pharma group in South America

14-01-2014

Colombia-based Grupo Biotoscana has signed an agreement to acquire Brazilian drugmaker United Medical…

Grupo BiotoscanaMergers & AcquisitionsPharmaceuticalSouth AmericaUnited Medical

moksha8 files Viibryd and Colobreathe in Brazil; amends Forest alliance

06-01-2014

Brazil-based pharma firm moksha8 has filed applications with the Brazilian regulatory authority, ANVISA,…

BrazilColoBreatheForest LaboratoriesLicensingMerck SeronoMoksha8NeurologicalPharmaceuticalRare diseasesRegulationSouth AmericaViibryd

Brazil National Health System coverage of and access to HIV drugs

Brazil National Health System coverage of and access to HIV drugs

27-12-2013

Brazil’s National Health System (SUS) currently provides coverage for 22 drugs that are distributed…

AbbVieAnti-viralsAtriplaBrazilEvipleraGilead SciencesGlaxoSmithKlineHealthcareKaletra TabletsMarkets & MarketingPharmaceuticalSouth AmericaTriovirTruvadaViread

Brazil’s ANS expands mandatory coverage for 29 genetic diseases

Brazil’s ANS expands mandatory coverage for 29 genetic diseases

26-12-2013

The Brazilian National Health Agency has authorized the criteria for the appropriate use of technology…

BrazilHealthcarePharmaceuticalRare diseasesSouth America

Two Latin America acquisitions for Gedeon Richter

23-12-2013

In what was a busy couple of days for Hungary’s largest drugmaker Gedeon Richter, the company announced…

BrazilGedeon RichterMergers & AcquisitionsNext PharmaPharmaceuticalSouth AmericaWomen's Health

OPKO Health to buy Lab Arama to expand Latin American presence

17-12-2013

Continuing on its acquisitive path, US drugmaker OPKO Health revealed that it has entered into an agreement…

Laboratorio AramaMergers & AcquisitionsOPKO HealthPharmaceuticalSouth America

6% annual growth forecast for NSCLC market in major Latin America countries

6% annual growth forecast for NSCLC market in major Latin America countries

12-12-2013

From 2013 to 2018, the non-small-cell lung cancer (NSCLC) market in Argentina, Brazil and Mexico will…

ArgentinaBrazilMarkets & MarketingOncologyPharmaceuticalSouth America

Brazil's regulatory processes impair the growth of pharma industry

Brazil's regulatory processes impair the growth of pharma industry

06-12-2013

The Brazilian pharmaceutical market is considered the second with the greatest growth potential in the…

BrazilPharmaceuticalRegulationSouth America

Grunenthal launches public tender offer to acquire Andromaco

04-12-2013

German family-owned drugmaker Grunenthal Group has now published its public tender offer to acquire all…

ChileGrunenthalLaboratorios AndromacoMergers & AcquisitionsPharmaceuticalSouth America

Emerging markets to see fastest growth, as pharma industry faces challenges

05-11-2013

Globally, the scientific foundation on which the pharma industry rests has improved vastly over the years.…

Asia-PacificMarkets & MarketingPharmaceuticalRegulationSouth America

1 to 25 of 99 results

Back to top